EMA Guideline shared facilities

On setting health exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities is in force as of June 1, 2015.

The method of calculation of an API Permitted Daily Exposure (PDE) is described in Appendix 3 of ICH Q3C (R4) and in appendix 3 of VICH GL. 18.

Socosur Azierta agreement:

  • Identification of “critical effects”.
  • Use of several adjustment factors to account for various uncertainties.

Latest news

CPhI 2017

Socosur is exhibiting on INDIS associates booth 80F02. During the exhibition an Azierta...(...)

AZIERTA exclusive agency for INDIA

The Azierta Socosur agreement on PDE, OEL, ICHQ and other toxicology services have been extended to...(...)

New Service - ICH Q3D

New service as part of Azierta cooperation: ICH Q3D – Elemental impurities Implementation of r...(...)

Exclusive agency for Azierta PDE monographs

Azierta and Socosur just entered an exclusive agency agreement for PDE monographs elaborated by...(...)

Stay in touch

Contact us